For arthrodesis of the tarsometatarsal joints, there is the possibility of using a transplant screw made of allogenic human bone material (Shark Screw). This article investigates the clinical outcome and radiologic integration of the allogenic bone screw for arthrodesis of the tarsometatarsal joints II/+III.
Methods:
This is a prospective study involving 20 feet of 17 patients who received TMT II/+III arthrodesis with an allogenic bone screw. A visual analog scale (VAS pain and function), Foot Function Index (FFI), American Orthopaedic Foot & Ankle Society (AOFAS) midfoot score, and Foot and Ankle Outcome Score (FAOS) were used as measures to compare preoperative with postoperative results. Radiologic integration in the recipient bone was also evaluated.
Results:
A significant mean pre- to postoperative improvement of all evaluated scores has been observed (P < .05) after a mean follow-up of 15.87 months (minimum 12 months, maximum 33 months). VAS score (pain) decreased from 7.6 to 1.4 points as well as a decrease of the VAS (function) from 7.25 to 1.8 points. Further, a reduction of the FFI from 62.3% to 16.7% and an increase from 29.7 to 79.9 points of the AOFAS was detected. Analyzing the FAOS score, in all surveyed subscales, there was an increase in the score (Symptoms: 55.2 to 85.6 points; Pain: 30.5 to 86.9 points; Function: 33.1 to 88.3 points; Quality of life: 27.8 to 79.7 points). Moreover, in all cases, a complete radiologic integration into the receiving bone was appreciated, and after a minimum follow-up time from 12 months, the screw in 19 feet (95%) was no longer distinguishable from the original bone.
Conclusion:
With these first results of the allogenic bone screw in TMT II/+III arthrodesis, a significant improvement from preoperative to postoperative was confirmed in the collected scores, and a full radiographic integration was demonstrated in all feet.
AronowMS. Treatment of the missed Lisfranc injury. Foot Ankle Clin. 2006;11(1):127-142. doi:10.1016/J.FCL.2005.12.005
2.
BanwartJCAsherMAHassaneinRS. Iliac crest bone graft harvest donor site morbidity: a statistical evaluation. Spine. 1995;20(9):1055-1066. doi:10.1097/00007632-199505000-00012
3.
BaumhauerJPinzurMSDonahueRBeasleyWDiGiovanniC. Site selection and pain outcome after autologous bone graft harvest. Foot Ankle Int. 2014;35(2):104-107. doi:10.1177/1071100713511434
4.
BijurPESilverWGallagherEJ. Reliability of the visual analog scale for measurement of acute pain. Acad Emerg Med. 2001;8(12):1153-1157. doi:10.1111/J.1553-2712.2001.TB01132.X
BöstmanOPihlajamäkiH. Routine implant removal after fracture surgery: a potentially reducible consumer of hospital resources in trauma units. J Trauma. 1996;41(5):846-849. doi:10.1097/00005373-199611000-00013
7.
BuckBEMalininTIBrownMD. Bone transplantation and human immunodeficiency virus: an estimate of risk of acquired immunodeficiency syndrome (AIDS). Clin Orthop Relat Res. 1989;240:129-136. doi:10.1097/00003086-198903000-00015
8.
BudaMHagemeijerNCKinkSJohnsonAHGussDDiGiovanniCW. Effect of fixation type and bone graft on tarsometatarsal fusion. Foot Ankle Int. 2018;39(12):1394-1402. doi:10.1177/1071100718793567
9.
Budiman-MakEConradKJRoachKE. The Foot Function Index: a measure of foot pain and disability. Journal of Clinical Epidemiology. 1991;44(6):561-570. doi:10.1016/0895-4356(91)90220-4
10.
BurroughsKEReimerCDFieldsKB. Lisfranc injury of the foot: a commonly missed diagnosis. Am Family Physician. 1998;58(1):118.
11.
BusamMLEstherRJObremskeyWT. Hardware removal: indications and expectations. J Am Acad Orthop Surg. 2006;14(2):113-120. doi:10.5435/00124635-200602000-00006
12.
CampanaVMilanoGPaganoE, et al. Bone substitutes in orthopaedic surgery: from basic science to clinical practice. J Mater Sci Mater Med. 2014;25(10):2445-2461. doi:10.1007/S10856-014-5240-2
13.
ChouLBMannRACoughlinMJMcPeakeWTMizelMS. Stress fracture as a complication of autogenous bone graft harvest from the distal tibia. Foot Ankle Int. 2007;28(2):199-201. doi:10.3113/FAI.2007.0199
14.
CricchioGLundgrenS. Donor site morbidity in two different approaches to anterior iliac crest bone harvesting. Clin Implant Dent Relat Res. 2003;5(3):161-169. doi:10.1111/j.1708-8208.2003.tb00198.x
15.
de PalmaLSantucciASabettaSPRapaliS. Anatomy of the Lisfranc joint complex. Foot Ankle Int. 1997;18(6):356-364. doi:10.1177/107110079701800609
16.
DelloyeC. Tissue allografts and health risks. Acta Orthop Belg. 1994;60(suppl 1):62-67.
17.
DelloyeCCornuODruezVBarbierO. Bone allografts: what they can offer and what they cannot. J Bone Joint Surg Br. 2007;89(5):574-579. doi:10.1302/0301-620X.89B5.19039
18.
DinizPPachecoJFloraM, et al. Clinical applications of allografts in foot and ankle surgery. Knee Surg Sports Traumatol Arthrosc. 2019;27(6):1847-1872. doi:10.1007/s00167-019-05362-0
19.
EttingerSAltemeierAStukenborg-ColsmanC, et al. Comparison of isolated screw to plate and screw fixation for tarsometatarsal arthrodesis including clinical outcome predictors. Foot Ankle Int. 2021;42(6):734-743. doi:10.1177/1071100720980014
20.
EttingerSHemmersbachLCSchwarzeM, et al. Biomechanical evaluation of tarsometatarsal fusion comparing crossing lag screws and lag screw with locking plate. Foot Ankle Int. 2022;43(1):77-85. doi:10.1177/10711007211033541
21.
FerrisLRVargoRAlexanderIJ. Late reconstruction of the midfoot and tarsometatarsal region after trauma. Orthop Clin North Am. 1995;26(2):393-406.
22.
GoldbergVMAkhavanS. Biology of bone grafts. In: LiebermanJFriedlaenderG, eds. Bone Regeneration and Repair: Biology and Clinical Applications. Humana (NJ); 2005:57-65.
23.
GoossensMde StoopN. Lisfranc’s fracture-dislocations: etiology, radiology, and results of treatment. A review of 20 cases. Clin Orthop Relat Res. 1983;176:154-162. doi:10.1097/00003086-198306000-00020
24.
GreenwaldASBodenSDGoldbergVMKhanYLaurencinCTRosierRN. Bone-graft substitutes: facts, fictions, and applications. J Bone Joint Surg Am. 2001;83:98-103. doi:10.2106/00004623-200100022-00007
HinsenkampMMuylleLEastlundTFehilyDNoëlLStrongDM. Adverse reactions and events related to musculoskeletal allografts: reviewed by the World Health Organisation Project NOTIFY. Int Orthop. 2012;36(3):633-641. doi:10.1007/s00264-011-1391-7
27.
IrelandLSpelmanD. Bacterial contamination of tissue allografts - experiences of the donor tissue bank of victoria. Cell Tissue Bank. 2005;6(3):181-189. doi:10.1007/s10561-005-7365-5
28.
JungHGMyersonMSSchonLC. Spectrum of operative treatments and clinical outcomes for atraumatic osteoarthritis of the tarsometatarsal joints. Foot Ankle Int. 2007;28(4):482-489. doi:10.3113/FAI.2007.0482
29.
KapoorCPatelAJhaveriMGolwalaP. Post-traumatic arthritis of the tarsometatarsal joint complex: a case report. Cureus. 2016;8(12):e923. doi:10.7759/cureus.923
30.
KitaokaHBAlexanderIJAdelaarRSNunleyJAMyersonMSSandersM. Clinical rating systems for the ankle-hindfoot, midfoot, hallux, and lesser toes. Foot Ankle Int. 1994;15(7):349-353. doi:10.1177/107110079401500701
31.
LaurencinCKhanYEl-AminSF. Bone graft substitutes. Expert Rev Med Devices. 2006;3(1):49-57. doi:10.1586/17434440.3.1.49
MacaulayANandyalaSVMillerCPGhorbanhoseiniMWalleyKCKwonJY. Potential for bias and the American Orthopaedic Foot and Ankle Society Ankle-Hindfoot Scoring System. Foot Ankle Spec. 2018;11(5):416-419. doi:10.1177/1938640017740675
34.
MahanKTHillstromHJ. Bone grafting in foot and ankle surgery - a review of 300 cases. J Am Podiatr Med Assoc. 1998;88(3):109-118. doi:10.7547/87507315-88-3-109
35.
MiglioriniFCuozzoFTorsielloESpieziaFOlivaFMaffulliN. Autologous bone grafting in trauma and orthopaedic surgery: an evidence-based narrative review. J Clin Med. 2021;10(19):4347. doi:10.3390/JCM10194347
36.
Moracia-OchagavíaIRodríguez-MerchánEC. Lisfranc fracture-dislocations: current management. EFORT Open Rev. 2019;4(7):430-444. doi:10.1302/2058-5241.4.180076
37.
MyeroffCArchdeaconM. Autogenous bone graft: donor sites and techniques. J Bone Joint Surg Am. 2011;93(23):2227-2236. doi:10.2106/JBJS.J.01513
38.
NaalFDImpellizzeriFMHuberMRippsteinPF. Cross-cultural adaptation and validation of the Foot Function Index for use in German-speaking patients with foot complaints. Foot Ankle Int. 2008;29(12):1222-1228. doi:10.3113/FAI.2008.1222
39.
NemecSAHabbuRAAndersonJGBohayDR. Outcomes following midfoot arthrodesis for primary arthritis. Foot Ankle Int. 2011;32(4):355-361. doi:10.3113/FAI.2011.0355
40.
PastlKSchimettaW. The application of an allogeneic bone screw for osteosynthesis in hand and foot surgery: a case series. Arch Orthop Trauma Surg. Published online April 8, 2021. doi:10.1007/S00402-021-03880-6
41.
PerugiaDBasileABattagliaAStopponiMDe SimeonibusAU. Fracture dislocations of Lisfranc’s joint treated with closed reduction and percutaneous fixation. Int Orthop. 2003;27(1):30-35. doi:10.1007/S00264-002-0396-7
42.
PonkilainenVTMattilaVMLaineHJPaakkalaAMäenpääHMHaapasaloHH. Nonoperative, open reduction and internal fixation or primary arthrodesis in the treatment of Lisfranc injuries: a prospective, randomized, multicenter trial – study protocol. BMC Musculoskelet Disord. 2018;19(1):301. doi:10.1186/S12891-018-2222-4
43.
PreidlerKWBrossmannJDaenenBGoodwinDSchweitzerMResnickD. MR imaging of the tarsometatarsal joint: analysis of injuries in 11 patients. Am J Roentgenol. 1996;167(5):1217-1222. doi:10.2214/AJR.167.5.8911184
44.
ReithGSchmitz-GrevenVHenselKO, et al. Metal implant removal: benefits and drawbacks – a patient survey. BMC Surg. 2015;15:96. doi:10.1186/S12893-015-0081-6
45.
RoosEMBrandssonSKarlssonJ. Validation of the foot and ankle outcome score for ankle ligament reconstruction. Foot Ankle Int. 2001;22(10):788-794. doi:10.1177/107110070102201004
46.
SchrattHEThermannHFröhlichSMeierRM. RichterBW. Funktionelle Langzeitergebnisse nach Versteifungsoperationen der tarsometatarsalen Gelenkreihe [Long-term functional results after fusion surgery of the tarsometatarsal joint series]. Der Unfallchirurg. Published online 1999:257-268.
47.
SiddiquiNAGaliziaMSAlmusaEOmarIM. Evaluation of the tarsometatarsal joint using conventional radiography, CT, and MR imaging. Radiographics. 2014;34(2):514-531. doi:10.1148/RG.342125215
48.
StevensKJBanulsM. Sciatic nerve palsy caused by haematoma from iliac bone graft donor site. Eur Spine J. 1994; 3(5):291-293. doi:10.1007/bf02226583
49.
TugwellBDPatelPRWilliamsIT, et al. Transmission of hepatitis C virus to several organ and tissue recipients from an antibody-negative donor. Ann Intern Med. 2005;143(9):648-654. doi:10.7326/0003-4819-143-9-200511010-00008
50.
van BergenCJASiereveltINHoogervorstPWaizyHvan DijkCNBecherC. Translation and validation of the German version of the foot and ankle outcome score. Arch Orthop Trauma Surg. 2014;134(7):897-901. doi:10.1007/s00402-014-1994-8
51.
van LieshoutEMMde BoerASMeuffelsDE, et al. American Orthopaedic Foot and Ankle Society (AOFAS) Ankle-Hindfoot Score: a study protocol for the translation and validation of the Dutch language version. BMJ Open. 2017;7(2):e012884. doi:10.1136/bmjopen-2016-012884
52.
WangWYeungKWK. Bone grafts and biomaterials substitutes for bone defect repair: a review. Bioact Mater. 2017;2(4):224-247. doi:10.1016/J.BIOACTMAT.2017.05.007
53.
WirthCJZichnerL. Tarsometatarsalgelenke [Tarsometatarsal joints]. Orthopädie Und Orthopädische Chirurgie. 2002:648-652.
54.
ZwippHRammeltSHolchMDahlenC. Die lisfranc-arthrodese nach fehlheilung [The Lisfranc arthrodesis after malhealing]. Unfallchirurg. 1999;102(12):918-923. doi:10.1007/s001130050506
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
